Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Return on Equity (2016 - 2025)

Macrogenics (MGNX) has disclosed Return on Equity for 10 consecutive years, with 0.6% as the latest value for Q4 2024.

  • On a quarterly basis, Return on Equity rose 38.0% to 0.6% in Q4 2024 year-over-year; TTM through Dec 2024 was 0.6%, a 38.0% increase, with the full-year FY2025 number at 0.87%, down 37.0% from a year prior.
  • Return on Equity was 0.6% for Q4 2024 at Macrogenics, up from 1.43% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.48% in Q3 2021 to a low of 1.44% in Q3 2022.
  • A 5-year average of 0.88% and a median of 0.8% in 2020 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: tumbled -96bps in 2022, then surged 85bps in 2023.
  • Macrogenics' Return on Equity stood at 0.77% in 2020, then rose by 1bps to 0.76% in 2021, then decreased by -20bps to 0.92% in 2022, then decreased by -7bps to 0.98% in 2023, then surged by 39bps to 0.6% in 2024.
  • Per Business Quant, the three most recent readings for MGNX's Return on Equity are 0.6% (Q4 2024), 1.43% (Q1 2024), and 0.98% (Q4 2023).